George Capuano

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy

Vlado Perkovic, Meg Jardine, Bruce Neal et al. · New England Journal of Medicine · 2019 · 6K citations · Full text

Medicine, Nephrology, Pharmacology +17

Dose-Ranging Effects of Canagliflozin, a Sodium-Glucose Cotransporter 2 Inhibitor, as Add-On to Metformin in Subjects With Type 2 Diabetes

Julio Rosenstock, Naresh Aggarwal, David Polidori et al. · Diabetes Care · 2012 · 420 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Canagliflozin and Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus and Chronic Kidney Disease in Primary and Secondary Cardiovascular Prevention Groups

Kenneth W. Mahaffey, Meg Jardine, Séverine Bompoint et al. · Circulation · 2019 · 288 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +17

Effects of Antipsychotic Medications on Psychosocial Functioning in Patients With Chronic Schizophrenia: Findings From the NIMH CATIE Study

Marvin S. Swartz, Diana O. Perkins, T. Scott Stroup et al. · American Journal of Psychiatry · 2007 · 285 citations

Pharmacy, Pharmacotherapy, Psychiatry +17

Efficacy and Safety of Canagliflozin, an Inhibitor of Sodium–Glucose Cotransporter 2, When Used in Conjunction With Insulin Therapy in Patients With Type 2 Diabetes

Bruce Neal, Vlado Perkovic, Dick de Zeeuw et al. · Diabetes Care · 2014 · 236 citations

Medicine, Pharmacology, Pharmacotherapy +17